Doximity, Inc. DOCS
26.35
0.31
1.19%
as of 25 Sep
- Market cap
- $4.6B
- P/E
- 29.6×
Follow DOCS
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
24.61% | 23.82% | 19.28% | 17.21% | |
| 21.30% | 20.56% | 16.42% | 14.60% | ||
ROIC |
71.03% | 61.12% | 66.42% | 53.13% | |
Return on Tangible Assets |
26.15% | 27.82% | 24.28% | 21.34% | |
Average Days of Receivables |
75.96 | 89.62 | 81.95 | 98.87 | |
Free Cash Flow per Share |
1.66 | 1.64 | 1.70 | 1.63 | |
Free Cash Flow |
312.11 | 307.27 | 317.56 | 297.03 | |
Capital Expenditures |
(7.61) | (8.15) | (8.90) | (9.32) | |
Piotroski F-Score |
7.00 | 5.00 | 4.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
16.20% | 18.40% | 19.21% | 19.10% | |
Accounts Receivable Turnover |
4.89 | 4.34 | 4.72 | 4.11 | |
Accounts Payable Turnover |
17.00 | 20.37 | 26.22 | 18.50 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
26.33 | 26.71 | 20.81 | 30.30 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.11) | (0.13) | (0.22) | (0.26) | |
Research and Development Expense of Revenue |
16.77% | 18.25% | 20.27% | 21.72% | |
Selling, General and Administrative Expense of Revenue |
33.71% | 34.06% | 35.50% | 36.75% | |
Share Based Compensation of Revenue |
14.29% | 16.14% | 18.86% | 20.82% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.26 | 1.32 | 1.67 | 1.83 | |
Depreciation/Fixed assets |
0.81 | 0.96 | 1.12 | 1.25 | |
Capex/Depreciation |
(0.60) | (0.50) | (0.44) | (0.39) | |
Revenue per Share |
3.31 | 3.40 | 3.45 | 3.59 | |
Operating CF per Share |
1.70 | 1.68 | 1.75 | 1.68 | |
Capex per Share |
(0.04) | (0.04) | (0.05) | (0.05) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
40.72% | 37.54% | 30.40% | 25.48% |
Columns are period end dates